Dr. Jourdy is a firm believer in the use of proven technological advances. As such, he was the first surgeon in the Westchester/Hudson Valley region to offer the use of PROPEL sinus implants as part of his commitment to the most up-to-date patient care. The PROPEL dissolvable implant was the first of a new category of products offering localized, controlled drug delivery directly to the sinus tissue, and backed by Level 1-A scientific evidence.
Once the sinuses have been surgically opened, Dr. Jourdy may elect to insert the spring-like implant which expands within the sinus cavities helping to maintain the surgical openings both mechanically and through the gradual but direct delivery of an anti-inflammatory topical steroid medication to the sinus lining as the implant dissolves. The PROPEL stents have been clinically proven to prevent obstruction of the sinuses following surgery. This results in improved post-operative outcomes, reducing the need for additional surgical procedures such as those due to scarring.’
Clinically Proven Benefits of PROPEL
- Decreased inflammation
- Decreased risk of scar tissue
- Decreased risk of sinus closure
- Decreased need for oral steroids
- Decreased need for post-operative procedures
PROPEL represents a medical breakthrough clinically proven to improve surgical outcomes for chronic sinusitis sufferers.
PROPEL is the first and only device clinically shown to keep the sinuses open after surgery, precisely deliver anti-inflammatory medication directly into the healing tissues, and then dissolve.
The innovative sinus stent decreases post-operative scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids and their potential side effects. At the same time, PROPEL’s spring-like, lightweight design means patients usually cannot even tell that it is there.
To learn more about the family of PROPEL products, visit the PROPEL website here.